Merck is known for its commitment to invest in R & D. The basic long-term investments are justifiable Merck when the company is facing extreme pressure benefits?
by
Ananth Raman
Inga Maurer,
William Schmidt
Source: Harvard Business School
13 pages.
Date Posted: April 23, 2012. Prod #: 612082-PDF-ENG
Merck: Solution Business Case based on the science of Operations
Related Case Solutions:
Vioxx: Too Risky for Merck
Merck: Managing Vioxx (A)
Merck: Investing in Science-Based Business (Abridged)
Merck: Investing in Science-Based Business (Abridged)
Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc.
Novartis AG: Science-Based Business
Bayer AG: Bidding to Win Merck’s OTC Business
The Science and Art of Business
Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal Cona & McDarby vs. Merck Video Supplement
Balancing Family and Business Needs at Merck KGaA